Butanedioic acid, ester with 1,2,3-propanetriol monooctadecanoate | 55840-14-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 甘油脂
• 英文名称: Butanedioic acid, ester with 1,2,3-propanetriol monooctadecanoate
• 英文别名: butanedioic acid;2,3-dihydroxypropyl octadecanoate
• CAS: 55840-14-7
• 化学式: C25H48O8
• 分子量: 476.6
• InChiKey: WSHAIDIHLZNVFW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.08
• 重原子数：
  33
• 可旋转键数：
  23
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  141
• 氢给体数：
  4
• 氢受体数：
  8

文献信息

• [EN] NOVEL ANTIMICROBIAL PEPTIDES AND THEIR APPLICATION<br/>[FR] NOUVEAUX PEPTIDES ANTIMICROBIENS ET LEUR APPLICATION
  申请人：INFINITEC ACTIVOS S L

  公开号：WO2015135896A1

  公开（公告）日：2015-09-17

  The present invention relates to a compound of formula (I) and to compositions comprising said compound, as well as the use of said compound and/or said compositions to prevent fungal and/or bacterial growth.

  本发明涉及式(I)的化合物，以及包含该化合物的组合物，以及使用该化合物和/或所述组合物来防止真菌和/或细菌生长。
• UV ABSORBER FORMULATIONS
  申请人：Acker Stephanie

  公开号：US20100111884A1

  公开（公告）日：2010-05-06

  Disclosed is a UV filter composition comprising (a) an organic UV absorber of formula (1), wherein R 1 and R 2 , independently of one another, are C 3 -C 18 alkyl; C 2 -C 18 alkenyl; a radical of the formula —CH 2 —CH(OH)—CH 2 —O-T 1 ; or R 1 and R 2 are a radical of the formula (4a); R 7 is a direct bond; a straight-chain or branched C 1 -C 4 alkylene radical or a radical of the formula (I) or (II); R 8 , R 9 and R 10 , independently of one another, are C 1 -C 18 alkyl; C 1 -C 18 alkoxy or a radical of the formula (III); R 11 is C 1 -C 5 alkyl; m 1 is a number from 1 to 4; p 1 is 0; or a number from 1 to 5; A 1 is a radical of the formula (1b), (1c) or (1d); R 3 is hydrogen; C 1 -C 10 alkyl; —(CH 2 CHR 5 —O)n 1 -T 2 ; or —CH 2 —CH(—OH)—CH 2 —O-T 2 ; R 4 is hydrogen; M; C 1 -C 5 alkyl; or —(CH 2 )m 2 —O-T 3 ; R 5 is hydrogen; or methyl; T 1 , T 2 and T 3 independently from each other are hydrogen; or C 1 -C 18 alkyl; Q 1 is C 1 -C 18 alkyl, M is a metal cation; m 2 is 1 to 4; and n 1 is 1-16, (b) dimethyl capramide, (c) a cosmetically acceptable carrier; and water.

  本发明公开了一种紫外线过滤组合物，包括（a）式（1）的有机紫外线吸收剂，其中R1和R2独立地是C3-C18烷基；C2-C18烯基；式—CH2—CH（OH）—CH2—O-T1的基团；或者R1和R2是式（4a）的基团；R7是直链或支链C1-C4烷基、式（I）或（II）的基团；R8、R9和R10独立地是C1-C18烷基、C1-C18烷氧基或式（III）的基团；R11是C1-C5烷基；m1是1至4的数字；p1是0或1至5的数字；A1是式（1b）、（1c）或（1d）的基团；R3是氢、C1-C10烷基、式—（CH2CHR5—O）n1-T2或式—CH2—CH（—OH）—CH2—O-T2；R4是氢、M、C1-C5烷基或式—（CH2）m2—O-T3；R5是氢或甲基；T1、T2和T3互相独立地是氢或C1-C18烷基；Q1是C1-C18烷基，M是金属阳离子；m2是1至4的数字；n1是1-16，（b）二甲基辛酰胺，（c）化妆品可接受载体；和水。
• Use of glycosaminoglycan lipid conjugates for inducing osteogenesis
  申请人：Tokyo Medical and Dental University

  公开号：EP1044691A2

  公开（公告）日：2000-10-18

  A novel medicine capable of inducing osteogenesis at lower dosage is provided. The osteogenesis inducing medicine contains a lipid-bound glycosaminoglycan, composed of a glycosaminoglycan conjugated with a lipid, or a pharmacologycally accepted salt of the lipid-bound glycosaminoglycan as the effective ingredient of the medicine.

  本研究提供了一种能够以较低剂量诱导成骨的新型药物。这种成骨诱导药物的有效成分是一种脂质结合型氨基多糖，由与脂质结合的氨基多糖或药理学上可接受的脂质结合型氨基多糖的盐组成。
• COMPOSITION FOR ORAL ADMINISTRATION
  申请人：FUJIFILM Corporation

  公开号：EP2668852A1

  公开（公告）日：2013-12-04

  A composition for oral administration includes: a water-insolubilized material including a bitter or astringent substance, such as an iso-α acid, and a polyvalent metal salt such as ferric chloride; and a dispersant such as a water-soluble macromolecule such as gelatin or gum arabic.

  一种用于口服的组合物包括：一种水不溶物，其中包括一种苦味或涩味物质，如异α酸，以及一种多价金属盐，如氯化铁；以及一种分散剂，如一种水溶性大分子，如明胶或阿拉伯树胶。
• Peptides for the stimulation of collagen formation
  申请人：Infinitec Activos, S.L.

  公开号：EP2832742A1

  公开（公告）日：2015-02-04

  The present invention relates to a compound of formula (I), i.e. R1-Arg-Gly-Asp-Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly-R2 and to compositions comprising said compound, as well as the use of said compound and/or said compositions in the cosmetic treatment of skin and/or hair, and to the use thereof for inducing the formation of collagen.

  本发明涉及一种式 (I) 的化合物，即 R1-Arg-Gly-Asp-Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly-R2，还涉及包含所述化合物的组合物，以及所述化合物和/或所述组合物在皮肤和/或头发的美容治疗中的用途，以及其在诱导胶原蛋白形成中的用途。